B7‐H3 expression and its correlation with clinicopathologic features, angiogenesis, and prognosis in intrahepatic cholangiocarcinoma
Authors:
Abstract
This study was designed to explore the expression of B7‐H3 in human intrahepatic cholangiocarcinoma (ICC) and its association with the clinicopathologic factors. In the current study, the expression of B7‐H3 in 45 patients with intrahepatic cholangiocarcinoma and 8 patients with hepatolithiasis was analyzed by immunohistochemistry, which revealed that B7‐H3 was not expressed in hepatolithiatic tissues, but positively expressed in 57.8% (26/45) of the ICC cases. The expression of B7‐H3 was significantly associated with lymph node metastases and venous invasion. A positive correlation was also observed between the expression of B7‐H3 and MVD, an index for tumor angiogenesis. Further survival analysis indicated that patients with B7‐H3 negative expression had higher overall survival (OS) and cancer‐specific survival (CSS) rates than those with B7‐H3 positive expression. Multivariate analysis revealed that B7‐H3 expression was an independent prognostic indicator for poor OS and CSS of ICC patients. Our results suggest that B7‐H3 may be a valuable biomarker in determining tumor progression and prognosis of intrahepatic cholangiocarcinoma. It is also a potential target for antivascular therapy of ICC.Keywords
Funding Information
- Middle-aged and Young Teachers’ Education Scientific Research Projects in Fujian Province, China (JAT170221)
This publication has 29 references indexed in Scilit:
- CholangiocarcinomaThe Lancet, 2014
- SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinomaInvestigational New Drugs, 2011
- Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cellsJournal of Gastroenterology, 2011
- Sorafenib in patients with advanced biliary tract carcinoma: a phase II trialBritish Journal of Cancer, 2009
- Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinomaEuropean Journal of Surgical Oncology, 2007
- Genes that Distinguish Physiological and Pathological AngiogenesisCancer Cell, 2007
- The Epidemiology of CholangiocarcinomaSeminars in Liver Disease, 2004
- Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?Journal of Hepatology, 2004
- Vasculogenic Mimicry and Tumor AngiogenesisThe American Journal of Pathology, 2000
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991